Blake Warner, DDS, PhD, MPH
Assistant Clinical Investigator
Salivary Disorders Unit
Building 30 B10 Room 1A08
30 Convent Dr MSC 4340
Bethesda MD 20892-4326
Blake M. Warner, DDS, PhD, MPH is currently an Assistant Clinical Investigator and Chief of the Salivary Disorders Unit and the Sjögren’s Syndrome Clinic. The integrated specialty clinic and associated laboratory focus on characterizing disorders affecting the salivary glands including autoimmune diseases and iatrogenic salivary damage by oncologic therapies. Specifically, we interrogate the clinical phenotype, genetics, and immunopathology of salivary dysfunction states including SS and immune checkpoint inhibitor-induced (ICI) sicca and to inform the clinical testing novel therapeutics to improve health outcomes.
Presently, the Salivary Disorders Unit is pursuing two focused research projects: i) investigating pathogenic T cell subsets in Sjögren’s Syndrome and immune checkpoint inhibitor sicca (ICIS, Warner et al., 2019, Burbelo et al., 2019), and ii) the identification of novel mechanisms of salivary dysregulation in genetic forms of Sjögren’s Syndrome. The laboratory uses patient-derived tissues to perform integrated tissue investigations using single cell RNA sequencing (scRNA-seq) and spatially-resolved RNA-seq (srRNA-seq) and robust clinical data to understand transcriptional state of each salivary cell type. The second aim is to identify unique subsets patients which phenocopy SS but with variants in pathways central to salivary function, or in genes that modify the development of autoimmunity. In studying rare disease variants, we open a window into the biology of complex autoimmune diseases.
Dr. Blake M. Warner received his B.S. in Biochemistry at the University of Miami in Oxford, OH, his M.P.H., Ph.D., and D.D.S. at The Ohio State University. Dr. Warner subsequently completed a three-year hospital-based clinical residency in Oral and Maxillofacial Pathology at the University of Pittsburgh Medical Center and earned his Fellowship in the American Association of Oral and Maxillofacial Pathology and his Board Certification by the American Board of Oral and Maxillofacial Pathology in 2017. Dr. Warner then completed a post-doctoral Clinical Research Fellowship at NIDCR focused on basic and clinical investigations in Sjögren’s Syndrome and radiation-induced xerostomia. In May of 2018, Dr. Warner was appointed acting chief of the Sjögren’s Syndrome Clinic and in August of 2019 was appointed Chief of the Salivary Disorders Unit and the Sjögren’s Syndrome Clinic. He leads an integrated multi-specialty clinic and aligned research laboratory focused on deep characterization of disorders affecting the salivary glands including autoimmune diseases and iatrogenic salivary damage by oncologic therapies. Specifically, we interrogate the clinical phenotype, genetics, and immunopathology of salivary dysfunction states including SS and immune checkpoint inhibitor-induced (ICI) sicca and to inform the clinical testing novel therapeutics to improve health outcomes.
Huang N, Pérez P, Kato T, Mikami Y, Okuda K, Gilmore RC, Conde CD, Gasmi B, Stein S, Beach M, Pelayo E, Maldonado JO, Lafont BA, Jang SI, Nasir N, Padilla RJ, Murrah VA, Maile R, Lovell W, Wallet SM, Bowman NM, Meinig SL, Wolfgang MC, Choudhury SN, Novotny M, Aevermann BD, Scheuermann RH, Cannon G, Anderson CW, Lee RE, Marchesan JT, Bush M, Freire M, Kimple AJ, Herr DL, Rabin J, Grazioli A, Das S, French BN, Pranzatelli T, Chiorini JA, Kleiner DE, Pittaluga S, Hewitt SM, Burbelo PD, Chertow D, NIH COVID-19 Autopsy Consortium., HCA Oral and Craniofacial Biological Network., Frank K, Lee J, Boucher RC, Teichmann SA, Warner BM, Byrd KM. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2021;27(5):892-903.
Warner BM, Baer AN, Lipson EJ, Allen C, Hinrichs C, Rajan A, Pelayo E, Beach M, Gulley JL, Madan RA, Feliciano J, Grisius M, Long L, Powers A, Kleiner DE, Cappelli L, Alevizos I. Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy. Oncologist. 2019;24(9):1259-1269.
Roy J, Warner BM, Basuli F, Zhang X, Zheng C, Goldsmith C, Phelps T, Wong K, Ton AT, Pieschl R, White ME, Swenson R, Chiorini JA, Choyke PL, Lin FI. Competitive blocking of salivary gland [18F]DCFPyL uptake via localized, retrograde ductal injection of non-radioactive DCFPyL: a preclinical study. EJNMMI Res. 2021;11(1):66.
Burbelo PD, Iadarola MJ, Keller JM, Warner BM. Autoantibodies Targeting Intracellular and Extracellular Proteins in Autoimmunity. Front Immunol. 2021;12:548469.
Yin H, Pranzatelli TJF, French BN, Zhang N, Warner BM, Chiorini JA, NIDCD/NIDCR Genomics and Computational Biology Core.. Sclerosing Sialadenitis Is Associated With Salivary Gland Hypofunction and a Unique Gene Expression Profile in Sjögren's Syndrome. Front Immunol. 2021;12:699722.
Related Scientific Focus Areas
Genetics and Genomics
Molecular Biology and Biochemistry
This page was last updated on December 5th, 2019